UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on West Pharmaceutical Services
In a report published Monday, Jefferies & Company reiterated its Hold rating on West Pharmaceutical Services (NYSE: WST), and raised its price target from $45.00 to $49.00.
Jefferies noted, “WST continues to see progress in shifting customers to high value (and higher margin) packaging products. The company has also benefited from accelerated demand from clients, who are building inventory and launching new products. We expected that to moderate sooner than now, but still expect it to diminish in the future. We are raising EPS based on the recent performance, while maintaining future growth rates.”
West Pharmaceutical Services closed on Friday at $52.66.
Latest Ratings for WST
|Mar 2016||Wells Fargo||Initiates Coverage on||Outperform|
|Jan 2016||Janney Capital||Initiates Coverage on||Buy|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.